Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20020585HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20020744HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20020745HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20019869HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20020243HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20020244HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20020245HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20020246HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20030905HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TCGA Plot Options
Drug Information
GeneCD274
DrugBank IDDB11945
Drug NameAvelumab
Target IDBE0003441
UniProt IDQ9NZQ7
Regulation Typeinhibitor
PubMed IDs23724846; 33807678
CitationsHamid O, Robert C, Daud A, Hodi FS, Hwu WJ, Kefford R, Wolchok JD, Hersey P, Joseph RW, Weber JS, Dronca R, Gangadhar TC, Patnaik A, Zarour H, Joshua AM, Gergich K, Elassaiss-Schaap J, Algazi A, Mateus C, Boasberg P, Tumeh PC, Chmielowski B, Ebbinghaus SW, Li XN, Kang SP, Ribas A: Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N Engl J Med. 2013 Jul 11;369(2):134-44. doi: 10.1056/NEJMoa1305133. Epub 2013 Jun 2.@@Kyriakidis I, Vasileiou E, Rossig C, Roilides E, Groll AH, Tragiannidis A: Invasive Fungal Diseases in Children with Hematological Malignancies Treated with Therapies That Target Cell Surface Antigens: Monoclonal Antibodies, Immune Checkpoint Inhibitors and CAR T-Cell Therapies. J Fungi (Basel). 2021 Mar 5;7(3). pii: jof7030186. doi: 10.3390/jof7030186.
GroupsApproved; Investigational
Direct ClassificationPeptides
SMILES
Pathways
PharmGKB
ChEMBL